Computational Analysis of Lianhua Qingwen as an Adjuvant Treatment in Patients with COVID-19

Wang et al., Society of Toxicology Conference, 2023

Wang et al., Computational Analysis of Lianhua Qingwen as an Adjuvant Treatment in Patients with COVID-19, Society of Toxicology Conference, 2023

Mar 2023 Source PDF

Twitter
Facebook

All Studies Meta

In Silico analysis of components of Lianhua Qingwen, identifying quercetin, luteolin, wogonin, and phillyrin as potentially beneficial for COVID-19. Authors note that quercetin bound to M^pro at the same inhibitory pocket as nirmatrelvir (paxlovid).

Important missing comments or errors? Let us know.

Wang et al., 31 Mar 2023, peer-reviewed, 5 authors.

In Silico studies are an important part of preclinical research, however results may be very different in vivo.

All Studies Meta Analysis Submit Updates or Corrections

This Paper Quercetin All

Download Image

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit